605077.SS Stock Analysis
60
Uncovered
Zhejiang Huakang Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Market cap $B
0.557
Dividend yield
3.10 %
Shares outstanding
228.46 B
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of functional sugar alcohols and starch sugar products. The company is headquartered in Quzhou, Zhejiang and currently employs 1,303 full-time employees. The company went IPO on 2021-02-09. The firm's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The firm conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.